Treatment with AKT inhibitors may also result in adverse reactions, including gastrointestinal discomfort, skin reactions, metabolic disorders, abnormal liver function, hematological abnormalities, cardiac toxicity, and immunosuppression (Glaviano et al., 2023). This evidence concerns the gene AKT1 and metabolic disease.